A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period

NCT00439400 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: doxycycline
DRUG: placebo

Sponsor

Alacrity Biosciences, Inc.